CRS01
Financial Strategies for Pharma, Med-Tech & Biotech In-Licensing Deals
Enhance your expertise in Pharma, Med-Tech, and Biotech licensing deals. Master essential financial accounting terms, understand strategic deal structures, and evaluate their financial implications with confidence.
Course overview
What you will learn
- Identify relevant financial statements and components for deal accounting.
- Understand key accounting terms and implications in licensing contracts.
- Assess how IP classification affects deal accounting.
- Mitigate income fluctuations due to R&D deal uncertainties.
- Evaluate accounting implications for in-licensing deals before deal signing.
- Understand the accounting impact of equity transfers.
- Utilise decision trees for pre-emptive deal accounting strategies.
Why you should attend
Most Business Development and Licensing executives in Pharma, Biotech, and Med-Tech lack a deep understanding of the accounting implications of their deals. This can lead to unexpected accounting treatments after signing. This course develops the skills to anticipate and manage deal accounting, helping to avoid surprises.
Real-life cases and interactive sessions provide actionable insights and help consolidate knowledge. Live courses are limited to 10 participants, creating opportunities to ask specific questions and share experiences with international peers.
Additional benefits
- Access expert guidance on your active deals.
- Engage in peer learning through pre-course questionnaires and live polling.
- Apply concepts through real-life case studies in small group settings.
- Learn from experienced and enthusiastic instructors.
- Benefit from clear, simplified communication.
- Acquire transferable knowledge for related business transactions.
Who should attend?
- Business Development Executives: Scouting and negotiating deals.
- Legal Executives: Drafting term sheets and contracts.
- Finance Executives: Understanding deal structures, legal terms, and accounting implications.
- Partnering Executives (Pharma, Biotech, Med-Tech): Sourcing complementary deals.
- R&D/Disease Biology Area (DBA) Executives: Clarifying the scientific aspects of IP transfers to finance teams.
- Marketing & Distribution Executives: Explaining marketing elements in deals to finance teams.
Executives from other professional service agencies should request approval before registering. Please contact sales@mioconsult.com.
Your instructor
Meet Michelle Olufeso-Nwokobia
Founder & CEO
Former Head of Accounting External Relations & Global Alliances at a Swiss pharmaceutical firm, with more than 15 years specialising in pharmaceutical accounting. Expertise includes licensing deals, business combinations, and IFRS implementation, with experience across Oil & Gas, Telecoms, and Financial Services.
Course dates
Choose how you would like to attend
Each course instance is linked to its delivery type. Confirmed dates will appear here as soon as they are published.
Published course times use Europe/Berlin time.
Self-paced
Learn independently online, on a schedule that works for you.
- Scheduled Online · Example date — edit before launch Example self-paced instance. Edit the access details before launch.
Live in person
Join an instructor-led workshop at the published venue.
- Scheduled Frankfurt area (example venue) · Example date — edit before launch Example in-person instance. Edit the venue and date before launch.
Online webinar (Zoom)
Join a live, instructor-led session online using Zoom.
- Scheduled Zoom · Example date — edit before launch Example live Zoom instance. Edit the date before launch.
Enrolment
Purchase CRS01
Select a delivery type and course instance. When sales are open, secure payment is completed on Stripe and access is issued only after Stripe confirms payment.